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Introduction
Small intestinal bacterial overgrowth (SIBO) occurs in varying frequency in irritable bowel syndrome (IBS). We studied the fre-
quency of SIBO in IBS and chronic non-specific diarrhea (CNSD). 
Methods
129 patients with IBS (Manning‘s criteria), 73 with CNSD (≥ 4 weeks diarrhea with two of these tests normal [urine D-xylose, 
fecal fat and duodenal biopsy]) and 51 healthy controls (HC) were evaluated for SIBO using glucose hydrogen breath test 
(GHBT). Diarrhea-predominant IBS (D-IBS) was grouped into CNSD. Rise in breath hydrogen 12 ppm above basal following 100 
g glucose was diagnostic of SIBO. 
Results
Of 129 patients with IBS, 7 were constipation (C-IBS), and 122 were of indeterminate type (I-IBS). Patients with IBS were 
younger than HC and CNSD (IBS vs. HC: 36.6 yr ± 11.4 vs. 44.1 yr ± 13.6, p = 0.001; IBS vs. CNSD: 36.6 yr ± 11.4 vs. 42 
yr ± 14.5, p = 0.003). Patients with CNSD were comparable to HC in age (42 yr ± 14.5 vs. 44.1 yr ± 13.6, p = ns). Patients 
with IBS were more often male than HC [108/129 (83.7%) vs. 34/51 (66.7%) p = 0.02]; gender of CNSD and HC was com-
parable [male 39/73 (53.4%) vs. 34/51 (66.7%) p = ns]. SIBO was commoner in CNSD than HC [16 (21.9%) vs. 1 (2%), p = 
0.003], but was comparable in IBS and HC [11 (8.5%) vs. 1 (2%), p = 0.18]. Patients with CNSD more often had SIBO than 
IBS [16 (21.9%) vs. 11 (8.5%), p = 0.007]. 
Conclusions
SIBO was more common in CNSD including D-IBS than other types of IBS and HC. 
(J Neurogastroenterol Motil 2010;16:40-46)
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Introduction
Irritable bowel syndrome (IBS) is a functional disorder char-
acterized by chronic or recurrent abdominal pain, abnormal bow-
el habits, bloating, passage of mucus, and feeling of incomplete 
evacuation.
1 IBS is common all over the world including Asia.
2 
The pathophysiology of IBS is poorly understood.
3 The current 
hypothesis is based on the biopsychosocial concept,
4 altered gas-
trointestinal motility,
5 disturbance of visceral hypersensitivity
6 
and infection.
7 Moreover, gut microbiota and certain intestinal 
pathogens are likely to contribute to pathogenesis of IBS.
8,9 Small 
intestinal bacterial overgrowth (SIBO) is a condition charac-
terized by abnormally high bacterial count (≥ 10
5 colony-form-
ing units/mL) in the proximal small intestine.
10 Symptoms of 
SIBO include abdominal pain, bloating and diarrhea, which are 
similar to those observed in patients with IBS.
11,12 However, 
there is scanty data on SIBO in patients with IBS from Asia.
8  
Chronic diarrhea resulting from malabsorption syndrome 
(MAS) due to various causes is associated with SIBO fre-
quently.
13 Patients with diarrhea-predominant IBS (D-IBS) may 
have SIBO more often than those without diarrhea.
14 In fact, 
there may be some pathophysiological and etiological overlap be-
tween D-IBS and mild malabsorption syndrome. This is evi-
denced by the fact that patients with post-infectious IBS 
(PI-IBS), who have organic basis more frequently, are more of-
ten diarrhea-predominant,
15,16 and have abnormal small intestinal 
permeability.
17 Also, patients with D-IBS may have SIBO
18 and 
lactose malabsorption
18 more frequently. Since IBS is diagnosed 
by criteria based on combination of symptoms,
19 which are com-
mon in patients with mild malabsorption syndrome,
8 it is possible 
that some of patients with the latter condition, at least with mild 
disease and at an early stage, may be diagnosed as IBS, partic-
ularly if tests for mucosal malabsorption are not performed in 
them. Such a contention is supported by the recent reports of cel-
iac disease diagnosed in patients presenting as IBS.
20-22 Hence, it 
is worthwhile to study whether patients with chronic non-specific 
diarrhea (CNSD), who do not have malabsorption documented 
by appropriate investigations, more often have SIBO? 
There are several methods for evaluation of SIBO. Lactulose 
hydrogen breath test (Lactulose HBT),
23 glucose hydrogen 
breath test (GHBT),
24 and culture of jejunal aspirate
25 are com-
mon tests used to diagnose SIBO. However, GHBT has been 
suggested to be an acceptable method to diagnose SIBO in clin-
ical practice as it is more specific than Lactulose HBT and is 
non-invasive as compared with quantitative jejunal aspirate 
culture.
8,26 Accordingly, we aimed to study the frequency of 
S I B O  i n  p a t i e n t s  w i t h  I B S  a n d  C N S D  i n  c o m p a r i s o n  w i t h  
healthy controls (HC) using GHBT. 
Materials and Methods
1. Study subjects
In this retrospective study, 129 patients with IBS diagnosed 
using Manning’s criteria
27,28, 73 with CNSD attending the out-
patient clinic of the Department of Gastroenterology of a tertiary 
referral center in the northern India and 51 HC were included. 
The study protocol was approved by the Institutional Ethics 
committee. Informed consent was obtained from all the patients 
and HC. Patients who received antibiotics, proton pump in-
hibitors and promotility or antimotility drugs within 4 weeks be-
fore inclusion into the study were excluded. 
2. Diagnostic criteria
Urine D-xylose, quantitative fecal fat and or microscopy of 
Sudan III-stained specimen and duodenal biopsy were per-
formed in patients with chronic diarrhea as indicated clinically.  
Chronic non-specific diarrhea was defined as non-bloody diar-
rhea (more than 3 semi-formed to liquid stools per day) for ≥ 4 
weeks with at least two of the following tests showing normal re-
sult [urine D-xylose, fecal fat or fecal Sudan and duodenal biop-
sy]. Patients with any two of the above tests abnormal (urine 
D-xylose <  0.8 g/5 g/5 hr, fecal fat > 7 g/day or fecal Sudan    
> 10 droplet per high power field (hpf), and villous atrophy in 
duodenal biopsy) were excluded from this study. Patients with 
IBS were further subclassified into diarrhea, constipation and in-
determinate type as reported previously.
29 Diarrhea-predominant 
patients with IBS were grouped into CNSD if the investigations 
for mucosal malabsorption, done as indicated, were normal. 
3. Investigations for mucosal malabsorption
1) Urine D-xylose
Urine D-xylose was estimated using colorimetric method after 
5 g D-xylose using a standard technique.
30 A value ≥ 0.8 g/5 g/5 
hr was considered normal. 
2) Fecal fat 
Fecal fat was estimated either over 72-hour using standard 
technique (Van de Kamer’s) after challenge with 75 g extra diet-
ary fat per day for 3 days prior to and during the test or by micro-Uday C. Ghoshal, et al
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Table 1. Demographic, Clinical, and Laboratory Parameters of Patients and Controls 
IBS CNSD  Healthy  controls 
Parameters p-value
(n = 129) (n = 73) (n = 51)
Age (mean ± SD) (yr) 36.6 ± 11.4 42 ± 14.5 44.1 ± 13.6 NS
a
Sex (male, %) 108 (83.7) 39 (53.4) 34 (66.7) NS
Urine D-xylose (median and range)  1.3 (0.36-2.3)  1.0 (0.2-2.4) - NS
  g/5 g/5 hr (n = 22) (n = 50) 
Fecal fat (g/day)  8.24 (5.3-15.1)  4.97 (2.6-25)  - 0.008
 (Van de Kamer’s) (n = 10) (n = 13)
Fecal sudan (median and range) 14 (6-20)  12 (6-25)  - NS
  (droplets/hpf) (n = 22) (n = 26)
Hemoglobin (mean ± SD) (g/dL) 13.4 ± 1.9  12.3 ± 2.0  - 0.002
(n = 80) (n = 54)
GHBT (positive) 11 (8.5%) 16 (21.9%) 1 (2%) 0.001
aPatients with IBS were younger than CNSD and Healthy controls.
IBS, irritable bowel syndrome; CNSD, chronic non-specific diarrhea; NS, not significant; GHBT, glucose hydrogen breath test; SD, standard deviation. 
The categorical data were analyzed using Chi-square test and continuous data were analyzed using Mann-Whitney U test and unpaired t test depending upon the data.
scopic examination of spot stool specimen stained with Sudan III 
stain.
31 An average value of fecal fat excretion > 7 g/day by the 
former or more than 10 droplets of fat per high power field on 
microscopy by the latter technique were considered abnormal. 
3) Duodenal histology 
Endoscopic biopsy obtained during esophagogastroduo-
denoscopy was subjected to histological examination after 
Hematoxylin and Eosin staining. Histological parameters in-
cluding villous morphology were evaluated by experienced 
pathologists.   
4. Glucose hydrogen breath test
Glucose hydrogen breath test was performed using a breath 
gas analyzer (Bedfont gastrolyzer, Bedfont Scientific Ltd., 
ME13QX, England) after an overnight fast. The subjects were 
asked to avoid slowly absorbed carbohydrates (like bread and po-
tato) and fiber the previous night as this might lead to high basal 
levels of hydrogen in the breath. Cigarette smoking and exercise 
were avoided two hours before and during the test, as hyper-
ventilation can cause changes in breath hydrogen content. The 
subjects were then asked to brush their teeth and rinse their 
mouth with antiseptic mouth wash (chlorhexidine) and tap water 
before the test, to eliminate early peak in hydrogen due to action 
of oral bacteria on the test sugars. An average of four values was 
taken as the basal breath hydrogen level. Subjects were then 
asked to take 100 g glucose dissolved in 200 mL water. Therea-
fter, breath hydrogen values were estimated every 15 minutes for 
the next 3 hours. Persistent rise in breath hydrogen > 12 ppm 
above basal (at least two readings) was considered diagnostic of 
SIBO.
25 Patients with high basal breath hydrogen levels were re-
tested on another day after ensuring all the above precautions.
5. Statistical methods
Categorical and continuous data were analyzed using 
Chi-square and Mann-Whitney U test, respectively. The 
one-way ANOVA was done to analyze mean of maximum hydro-
gen excretion in three different groups. The time by group inter-
action was analyzed using repeated measures ANOVA (general 
linear model).
Results
Demographic, clinical and laboratory parameters of the study 
subjects are shown in Table 1. Patients with IBS were younger 
than HC (mean age 36.6 ± 11.4 yr vs. 44.1 ± 13.6 yr, p = 
0.001) and those with CNSD (mean age 36.6 ± 11.4 yr vs. 42 ±
14.5 yr, p = 0.003), respectively. Patients with CNSD were 
comparable in age with that of HC (mean age 42 ± 14.5 yr vs. 
44.1 ± 13.6 yr, p = ns). Patients with IBS were more often male 
than HC [108/129 (83.7%) vs. 34/51 (66.7%) p = 0.02]. 
However, CNSD and HC were comparable with respect to gen-
der [male 39/73 (53.4%) vs. 34/51 (66.7%) p = 0.28]. Of 129 
patients with IBS; 7 (5.4%) and 122 (94.6%) were constipation 
predominant (C-IBS), and indeterminate type (I-IBS), respec-
tively. A total of 20 patients with D-IBS were included in CNSD. 
A total of 7 patients with IBS and 6 patients with CNSD were ex-
cluded from the study as two or more tests of mucosal mal-
absorption were abnormal in them. Two patients each with IBS Small Bowel Bacterial Overgrowth in FBD
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Table 2. Report of D-xylose, Fecal Fat and Duodenal Biopsy in 
Patients with IBS and CNSD
Patients who had all the three tests
(urine D-xylose, fecal fat/fecal sudan and 
duodenal biopsy)
Normal Abnormal
IBS (n = 1) 1 0
CNSD (n = 5) 5 0
Patients who had two tests done
(any two of urine D-xylose, fecal fat/fecal
sudan and duodenal biopsy)
Normal Abnormal
IBS (n = 14) 4 0
                                         (one test normal and one
                                      abnormal n = 10)
CNSD (n = 28) 9 0
                                  (one test normal and
                                          one abnormal n = 19)
Patients who had only one test done 
(any one of urine D-xylose, fecal fat/fecal sudan 
and duodenal biopsy)
Normal Abnormal
IBS (n = 18) 7 11
CNSD (n = 7) 5   2
IBS, Irritable bowel syndrome; CNSD, chronic non-specific diarrhea. 
In 96/129 and 25/73 patients with IBS and CNSD, no test was done.
The patients with IBS and CNSD having no test done were diagnosed only on 
the basis of symptoms (no history of blood in stool, no weight loss, no alarm 
symptoms).
Figure 1. The time by group interaction showing the correlation of 
hydrogen excretion at different time interval on GHBT 
in patients with IBS, CNSD, and HC. The data was 
analyzed using repeated measures ANOVA using 
general linear model for the time by group interaction in 
both the analysis. IBS, irritable bowel syndrome; CNSD, 
chronic non-specific diarrhea; HC, healthy control.
had cyst of Giardia lamblia and cyst of Entamoeba histolytica on 
stool microscopy. Only one patient with CNSD had cyst of 
Giardia lamblia. 
1. Results of investigations for mucosal malabsorption
1) Urine D-xylose
Results of investigations for mucosal malabsorption are 
shown in Table 2. Urine D-xylose was done in 22/129 (17.1%) 
patients with IBS and 44/73 (60.3%) with CNSD. The urinary 
excretion of D-xylose was comparable in patients with IBS and 
CNSD (median 1.3 g/5 g/5 hr, range 0.36-2.3 g/5 g/5 hr vs. 1.0 
g/5 g/5 hr, range 0.2-2.4 g/5 g/5 hr, p = ns). 
2) Fecal fat
Fecal fat (by Van de Kamer’s method) was done in 10/129 
(7.7%) patients with IBS and 13/73 (17.8%) with CNSD. Fecal 
fat excretion was lower in patients with IBS as compared to pa-
tients with CNSD (median 8.24 g, range 5.3-15.1 g  vs. 4.97 g, 
range 2.6-25.1 g, p = 0.008). Fecal fat (Sudan stain) was done in 
22/129 (17.1%) patients with IBS and 26/73 (35.6%) with 
CNSD. Fecal fat excretion (droplets/hpf) was comparable in pa-
tients with IBS and CNSD (median 14 droplets/hpf, range 6-20 
droplets/hpf vs. 12, range 6-25 droplets/hpf, p = 0.29). 
2. Results of histopathological examination of duodenal 
biopsy
The histological evaluation of duodenal biopsy was done in 
26/73 patients with CNSD; of them, normal villous patterns was 
seen in 21 (80.8%), increased intraepithelial lymphocytes in 4 
(15.4%) and giardiasis in 1 (3.8%). None had villous atrophy. 
No patient with IBS underwent histological examination of duo-
denal biopsy as this is an invasive test. 
3. Result of glucose hydrogen breath test
Patients with CNSD more often had SIBO diagnosed by 
GHBT compared to patients with IBS and HC [16/73 (21.9%) 
vs. 11/129 (8.5%) vs. 1/51 (2%), respectively; p = 0.001] 
(Table 1). The frequency of SIBO was higher in patients with 
CNSD than HC (p = 0.003) but was comparable between pa-
tients with IBS and HC (p = 0.18). Also, the frequency of 
SIBO was higher in patients with CNSD than patients with IBS 
(p = 0.007).Uday C. Ghoshal, et al
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Table 3. Demographic, Clinical and Laboratory Parameters of the
Patients with and without Small Intestinal Bacterial 
Overgrowth
No SIBO SIBO present
                p-value
(n = 173) (n = 29)
Age (yr) 35 (17-75) 49 (22-84) < 0.001
Sex  (Male) 131 (76.0%) 16 (55.1%) 0.144
Chronic diarrhea 37 (21.4%) 16 (55.2%) 0.0006
  with negative tests
  for MAS (n = 53)
C-IBS (n = 7) 7 (4.0%) 0 (0%) 0.59
D-IBS (n = 19) 18 (10.4%) 2 (6.9%) 0.47
I-IBS (n = 122) 111 (64.2%) 11 (40.0%) 0.02
Basal breath   5 (0-21) 6 (0-18) 0.396
  hydrogen (ppm)
Maximum breath  7 (0-31) 28 (10-156) < 0.001
  hydrogen (ppm)
Urinary excretion of  1.17 (0.2-1.96) 0.94 (0.26-2.4) 0.748
  D-xylose (g/5 g/5 hr)
Fecal fat (g/24 hr) 6.5 (2.6-25) 4.7 (3.9-12.9) 0.438
Hemoglobin (g/dL) 13.5 (7-18.8) 12.4 (7.2-14.9) 0.006
MAS, malabsorption syndrome; IBS, Irritable bowel syndrome; C, D, and I 
indicate constipation predominant, diarrhea predominant, and indeterminate 
subtypes of IBS.
All the continuous data are presented as median and range. Values within 
parenthesis indicate percentages. 
11/122 (9.9%) of I-IBS, and none (0%) of C-IBS had SIBO 
(p = ns). The difference in frequency of SIBO in patients with 
D-IBS and other patients with CNSD was not significant [2/20 
(10%) vs. 16/53 (30.2%) p = 0.13]. The maximum hydrogen 
excretion was higher in patients with CNSD as compared to pa-
tients with IBS and HC (mean 19.3 ppm ± 27.9 ppm vs. 10.9
± 15 ppm vs. 8.5 ± 9.6 ppm, p = 0.003, Sum of square =
8,333.8), respectively. There was significant correlation for time 
by group interaction for hydrogen excretion at different time 
within the groups, p = 0.04, type III sum of square = 1512.68 
(Fig. 1). The maximum hydrogen excretion in patients with 
D-IBS, C-IBS and I-IBS was comparable (mean 8.3 ± 7.9 ppm 
vs. 9.1 ± 8.8 vs. 11.1 ± 15.3 ppm, p = 0.71). 
Discussion
The present study showed that SIBO was more common in 
patients with CNSD (21.9%) than those with IBS (8.5%) and 
HC (2%). 9.9% patients with I-IBS and none of C-IBS had 
SIBO. Also, patients with CNSD had more breath hydrogen ex-
cretion following glucose ingestion than IBS and HC.
Previous studies reported contradictory results on the preva-
lence of SIBO in patients with IBS.
14,32-36 The difference in the 
geographical origin of the studied population, criteria for diag-
nosis of IBS, methods for diagnosis of SIBO and methods of 
breath tests (substrate, instrument, gases analyzed, and diag-
nostic criteria) might explain the variation in prevalence of SIBO 
in different studies. In the present study, we have used 
Manning’s criteria for diagnosis of IBS instead of more recent 
Rome criteria. Rome criteria has limitations for diagnosis of IBS 
in Asia,
2,37 particularly in India as almost one-third of patients 
with IBS did not report pain or discomfort in a large study in 
India.
29 Other studies from India supported similar finding.
38 
Pain and discomfort are essential for diagnosis of IBS according 
to Rome criteria. Classification of IBS into D-IBS and C-IBS al-
so posed difficulty using Rome criteria as stool frequency was an 
important factor in classifying IBS using Rome I and II criteria. 
In fact, considering this, the recent Rome III criteria gave less 
importance to stool frequency. In many Asian studies, bloating, 
feeling of incomplete evacuation and meal-related symptoms 
were the common features of IBS
2,39 and stool frequency was 
comparable among patients who felt constipated or those who felt 
having diarrhea.
29 In fact, for this reason, in a large study from 
India, 57% were I-IBS.
29 Similar experience has also been re-
ported from some other Asian countries.
2 
Higher frequency of SIBO in patients with CNSD is not en-
tirely unexpected. Almost half of patients with MAS have been 
shown to have SIBO,
13 which might be related to small intestinal 
stasis in association with large quantity of nutrient-rich fluid in 
the lumen. In fact, there could be etiologic and pathophysiologic 
overlap between MAS and D-IBS as  evidenced by the fact that 
patients with PI-IBS, who have organic basis more frequently, 
are more often diarrhea-predominant like post-infective mal-
absorption syndrome,
15,16 and have abnormal small intestinal per-
meability,
17 Also, patients with D-IBS may have SIBO
18 and lac-
tose malabsorption
18 more frequently. These findings may sug-
gest that patients with chronic diarrhea, even if non-specific and 
D-IBS should be investigated for SIBO. Since our study was ret-
rospective, need to investigate for malabsorption such as D-xy-
lose test, fecal fat estimation and duodenal biopsy was decided by 
the clinicians; hence, every patient did not get all these tests done. 
Even if we have misclassified some patients with mild mal-
absorption into CNSD, our results are of importance in clinical 
practice. Secondary SIBO is common in patients with MAS due 
to various causes.
40 If SIBO is found in patients with chronic di-
arrhea, specific treatment with antibiotics may benefit them. Small Bowel Bacterial Overgrowth in FBD
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Since older patients had SIBO more commonly (Table 3), we 
suggest that patients older than 40 yr should be investigated for 
SIBO. Though hemoglobin was lower in patients with SIBO 
(Table 3), this might not be of clinical significance as most of the 
patients with SIBO had hemoglobin values within the normal 
range. 
Patients with CNSD produced more hydrogen following 
glucose ingestion than the patients with I-IBS, D-IBS, and HC. 
Gastrointestinal symptoms like bloating, flatulence and pain, 
which are common in patients with IBS and CNSD, can result 
from excess gas production from bacterial fermentation of un-
digested carbohydrates.
41 Patients with SIBO produce excess 
gases (i.e. hydrogen); moreover, gas distribution in the gut is ab-
normal in them with accumulation in small rather than in large 
intestine.
33 Development of symptoms following production of 
gas during hydrogen breath test in patient with IBS but not 
among HC has been documented during lactose hydrogen 
breath test.
24 Gas accumulation in the small intestine may lead to 
symptom development due to its limited capacity to distend in 
contrast to colon, which can accommodate large amount of gas 
without discomfort.
33 One of 51 HC in the current study had 
SIBO. None of them reported any gastrointestinal symptoms in-
dicative of IBS or other functional bowel disorders. This data is 
in accordance with those reported previously showing SIBO in 
1% of HC using GHBT.
36 
In conclusion, the present study showed that CNSD includ-
ing D-IBS had higher frequency of SIBO than I-IBS and 
C-IBS. Therefore, clinicians treating patients with CNSD in-
cluding D-IBS should consider testing for SIBO in them. 
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